Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418 / Maucher, Iv; Rühl, M; Kretschmer, Sb; Hofmann, B; Kühn, B; Fettel, J; Vogel, A; Flügel, Kt; Manolikakes, G; Hellmuth, N; Häfner, Ak; Golghalyani, V; Ball, Ak; Piesche, M; Matrone, C; Geisslinger, G; Parnham, Mj; Karas, M; Steinhilber, D; Roos, J; Maier, Tj.. - In: BIOCHEMICAL PHARMACOLOGY. - ISSN 0006-2952. - 125:(2017), pp. 55-74. [10.1016/j.bcp.2016.11.004]

Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418

Matrone C;
2017

2017
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418 / Maucher, Iv; Rühl, M; Kretschmer, Sb; Hofmann, B; Kühn, B; Fettel, J; Vogel, A; Flügel, Kt; Manolikakes, G; Hellmuth, N; Häfner, Ak; Golghalyani, V; Ball, Ak; Piesche, M; Matrone, C; Geisslinger, G; Parnham, Mj; Karas, M; Steinhilber, D; Roos, J; Maier, Tj.. - In: BIOCHEMICAL PHARMACOLOGY. - ISSN 0006-2952. - 125:(2017), pp. 55-74. [10.1016/j.bcp.2016.11.004]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/724225
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact